Showing results (61-70 of 652) with videos related to

Sort By:
Pageof 66
Vascular Health and Risk Management|February 6, 2020
Spotlight on Icosapent Ethyl for Cardiovascular Risk Reduction: Evidence to DateXiaoming Jia, Stephanie Koh, Mahmoud Al Rifai, et al.
Cardiovascular Drugs and Therapy|June 1, 2023
The Clinical Efficacy and Safety of Bempedoic Acid in Patients at Elevated Risk of Cardiovascular Disease: A Meta-Analysis of Randomized Clinical TrialsAhmed Sayed, Omar Shazly, Leandro Slipczuk, et al.
The American Journal of Cardiology|December 28, 2020
Trends and Predictors of Transcatheter Aortic Valve Implantation Related In-Hospital Mortality (From the National Inpatient Sample Database)Waqas Ullah, Salman Zahid, Ihab Hamzeh, et al.
Atherosclerosis|April 8, 2014
Rare LPL gene variants attenuate triglyceride reduction and HDL cholesterol increase in response to fenofibric acid therapy in individuals with mixed dyslipidemiaFeng Gao, Christie Ballantyne, Li Ma, et al.
Vascular Health and Risk Management|July 28, 2022
PCSK9 Inhibitors in the Management of Cardiovascular Risk: A Practical GuidanceXiaoming Jia, Mahmoud Al Rifai, Anum Saeed, et al.
Current Atherosclerosis Reports|November 20, 2019
Highlights from Selected Cardiovascular Disease Prevention Studies Presented at the 2019 European Society of Cardiology CongressXiaoming Jia, Mahmoud Al Rifai, Ty J Gluckman, et al.
Journal of Clinical Lipidology|December 27, 2017
Clinical pharmacist understanding of the 2013 American College of Cardiology/American Heart Association cholesterol guidelineJohn D Bucheit, Haleigh Helsing, Pramit Nadpara, et al.
Reviews in Medical Virology|September 22, 2020
Coronavirus disease-19 and cardiovascular disease: A risk factor or a risk marker?Jing Liu, Salim S Virani, Mahboob Alam, et al.
Current Atherosclerosis Reports|January 4, 2021
Highlights from Studies Presented at the American Heart Association Scientific Session 2020: Navigating New Roads in PreventionAliza Hussain, Mahmoud Al Rifai, Dhruv Mahtta, et al.
Journal of Clinical Lipidology|August 16, 2021
Greater than expected reduction in low-density lipoprotein-cholesterol (LDL-C) with bempedoic acid in a patient with heterozygous familial hypercholesterolemia (HeFH)Ali M Agha, Peter H Jones, Christie M Ballantyne, et al.
Pageof 66